Federal Register Notice: FDA’s proposed collection of information “Requirements for Submission of In Vivo Bioequivalence Data — 21 CFR parts 314 and 320” has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
